Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (56)
- Committees and advisory bodies (45)
- Safety monitoring and information (12)
- Advertising (9)
- Manufacturing (9)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Clinical trials (3)
- Legislation (3)
- Medicinal cannabis hub (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
247 result(s) found, displaying 226 to 247
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and the joint ACCS-ACMS
-
Corporate reportsFind out when software is classified as an in vitro medical device and how it is regulated.
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and the joint ACCS-ACMS
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, the joint ACCS and ACMS and ACMS
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS and the joint ACCS-ACMS
-
Scheduling submissionsPublic submissions on DMAA referred to ACMS
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS and ACMS
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS and ACMS
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS and ACMS
-
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and joint ACCS-ACMS
-
Corporate reportsInformation on Conformity Assessment of in vitro diagnostic medical devices (IVDs).
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS-ACMS and ACMS
-
Corporate reportsThis Code supersedes the November 1991 edition of the Australian Code of Good Wholesaling Practice for Therapeutic Goods for Human Use.
-
Corporate reportsThe use Global Medical Device Nomenclature (GMDN) codes for in vitro diagnostic medical devices supplied in Australia.
-
Corporate reportsThe NCCTG Scheduling Policy Framework outlines how medicines and chemicals are classified and regulated in Australia to support safe and consistent decision-making.
-
Corporate reports
-
Corporate reportsA publication about the history of therapeutic goods regulation in Australia, from the early 1900s up to 2007.
-
Corporate reportsGuidelines for sterility testing of medicines and medical devices supplied in Australia for human use.
-
Corporate reports
-
Corporate reportsThe IRIS is responsible for the management of all reports of adverse events or problems associated with medical devices that are reported to the TGA.
-
Corporate reportsNote for guidance on clinical safety data management: definitions and standards for expedited reporting